Cargando…
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
Glycated hemoglobin (HbA1c) is widely accepted as the most reliable measure of long‐term glycemia. However, there is disagreement among professional medical societies on a proper glycemic target for long‐term benefits in type 2 diabetes (T2D). The use of some glucose‐lowering drugs was associated wi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612881/ https://www.ncbi.nlm.nih.gov/pubmed/31312579 http://dx.doi.org/10.1002/jgf2.244 |